rs11188150
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000770.3(CYP2C8):c.1059C>T(p.His353=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00553 in 1,614,018 control chromosomes in the GnomAD database, including 202 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0037 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0057 ( 191 hom. )
Consequence
CYP2C8
NM_000770.3 synonymous
NM_000770.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.775
Genes affected
CYP2C8 (HGNC:2622): (cytochrome P450 family 2 subfamily C member 8) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, benzo(a)pyrene, 7-ethyoxycoumarin, and the anti-cancer drug taxol. This gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 10-95042980-G-A is Benign according to our data. Variant chr10-95042980-G-A is described in ClinVar as [Benign]. Clinvar id is 775289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-95042980-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.775 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0037 (564/152270) while in subpopulation SAS AF= 0.0498 (240/4822). AF 95% confidence interval is 0.0446. There are 11 homozygotes in gnomad4. There are 332 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 11 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP2C8 | NM_000770.3 | c.1059C>T | p.His353= | synonymous_variant | 7/9 | ENST00000371270.6 | |
CYP2C8 | NM_001198853.1 | c.849C>T | p.His283= | synonymous_variant | 7/9 | ||
CYP2C8 | NM_001198855.1 | c.849C>T | p.His283= | synonymous_variant | 8/10 | ||
CYP2C8 | NM_001198854.1 | c.753C>T | p.His251= | synonymous_variant | 6/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP2C8 | ENST00000371270.6 | c.1059C>T | p.His353= | synonymous_variant | 7/9 | 1 | NM_000770.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00369 AC: 562AN: 152152Hom.: 11 Cov.: 32
GnomAD3 genomes
AF:
AC:
562
AN:
152152
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00882 AC: 2217AN: 251478Hom.: 67 AF XY: 0.0113 AC XY: 1541AN XY: 135914
GnomAD3 exomes
AF:
AC:
2217
AN:
251478
Hom.:
AF XY:
AC XY:
1541
AN XY:
135914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00572 AC: 8355AN: 1461748Hom.: 191 Cov.: 32 AF XY: 0.00734 AC XY: 5334AN XY: 727176
GnomAD4 exome
AF:
AC:
8355
AN:
1461748
Hom.:
Cov.:
32
AF XY:
AC XY:
5334
AN XY:
727176
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00370 AC: 564AN: 152270Hom.: 11 Cov.: 32 AF XY: 0.00446 AC XY: 332AN XY: 74442
GnomAD4 genome
AF:
AC:
564
AN:
152270
Hom.:
Cov.:
32
AF XY:
AC XY:
332
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
65
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 16, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at